On September 29, California Governor Arnold Schwarzenegger signed into law a bill (S.B. 1765) that requires pharmaceutical companies that do business in California to adhere to the OIG guidance and PhRMA Code. Among the requirements is that pharma companies doing business in California develop a compliance program and detail the amount of promotional money they'll spend on physicians annually. The deadline: July 1, 2005.
Did Cephalon cross the off-label li